In previous studies, polymorphisms in the genes that encode TPH1, TPH2, IDO1 and KMO have been found to modulate the risk of depression development (Wigner et al. 2018a, b; Lezheiko et al. 2016). This evidence concerns the gene IDO1 and depressive symptom measurement.